# Ripk1 is critical for preserving effector regulatory T cells and the suppressive transcriptional program in regulatory T cells

**Authors:** Carlos Plaza-Sirvent, Hannah Sturm, Maximilian K. Nocke, Fatemeh Ghorbani, Clara Bessen, Marina C. Greweling-Pils, Stefan Floess, Jana Niemz, Jelle Huysentruyt, Peter Tougaard, Jochen Huehn, Robert Geffers, Daniel Todt, Peter Vandenabeele, Ingo Schmitz

PMC · DOI: 10.1038/s41418-025-01550-3 · Cell Death and Differentiation · 2025-07-22

## TL;DR

Ripk1 is essential for maintaining regulatory T cells and their ability to suppress immune responses, preventing immune-related diseases.

## Contribution

This study reveals that Ripk1 is critical for preserving the function and transcriptional program of effector regulatory T cells.

## Key findings

- Ablation of Ripk1 in Treg cells leads to reduced numbers and spontaneous whole-body pathology.
- Ripk1 is required to maintain the effector Treg cell transcriptional signature.
- Ripk1-deficient Treg cells show reduced viability in the presence of TNF.

## Abstract

Ripk1 plays an important role as a regulator of programmed cell death processes such as apoptosis and necroptosis and is involved in initiating pro-inflammatory NF-κB signaling. Immune tolerance depends on the proper function and homeostasis of regulatory T (Treg) cells. Here, we show that specific ablation of Ripk1 in Treg cells leads to systemically reduced Treg cell numbers resulting in spontaneous whole-body pathology. Using chimeric mice that allowed us to study Treg cells in the absence of inflammatory conditions, we observed a competitive disadvantage in vivo of Ripk1-deficient compared to Ripk1-proficient Treg cells. Furthermore, single-cell RNA sequencing revealed that Ripk1 is required for the maintenance of the effector Treg cell transcriptional signature, which is essential to prevent immune dysregulation. To overcome the limitation of low cell numbers in the chimeric mice, we isolated Treg cells from mice, in which Ripk1 could be deleted in a tamoxifen-inducible manner. Despite the strong reduction detected in Ripk1-deficient Treg cells of the chimeric mice, we did not observe impaired viability by the sole absence of Ripk1 in Treg cells from the inducible system. Of note, we observed reduced viability of activated Ripk1-deficient Treg cells in the presence of TNF. Together, these findings highlight the fundamental role of Ripk1 in maintaining immune homeostasis by preserving the highly suppressive effector Treg cells.

## Linked entities

- **Genes:** RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737]
- **Chemicals:** TNF (PubChem CID 8521)

## Full-text entities

- **Genes:** Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) [NCBI Gene 19766] {aka D330015H01Rik, RIP, RIP-1, Rinp, Rip1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}
- **Diseases:** inflammatory (MESH:D007249), immune dysregulation (OMIM:614878)
- **Chemicals:** tamoxifen (MESH:D013629)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881586/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881586/full.md

---
Source: https://tomesphere.com/paper/PMC12881586